Merrimack to shelve lead cancer drug, lay off most of workforce
November 08, 2018 at 10:17 AM EST
The biotech said it has also "retained external advisors to explore strategic alternatives," suggesting it may consider a sale.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.